Tech Stock News
Wednesday, September 28, 2022
Hoth Therapeutics Inc (NASDAQ: HOTH) is pleased to announce its Cohort 1 results. This trial happens to be the first time this patient-focused Biopharmaceutical Company is engaging in a clinical trial focused on eczema treatment. Focusing on the results The other name for the condition mentioned above is atopic dermatitis. It […]
Hoth Therapeutics Inc. (NASDAQ: HOTH) shares gained 12.9% after the company signed a Sponsored Research Agreement with Washington University to support research and development of HT-ALZ- HT-ALZ is a novel treatment for Alzheimer’s disease symptoms. Hoth Therapeutics partners with Washington University School of Medicine Washington University School of Medicine’s Carla […]